Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Eric Sirois"'
Publikováno v:
Artificial Organs. 42:E141-E152
Clinical use of transcatheter aortic valves (TAVs) has been associated with abnormal deployment, including oval deployment and under-expansion when placed into calcified aortic annuli. In this study, we performed an integrated computational and exper
Publikováno v:
Artificial Organs. 40:612-619
Impairment of coronary artery flow, in either acute or chronic conditions, is a severe complication of transcatheter aortic valve (TAV) implantation, which can arise due to improper TAV positioning. However, little work has been done to quantify the
Publikováno v:
Annals of Biomedical Engineering. 41:577-586
Success of the deployment and function in transcatheter aortic valve replacement (TAVR) is heavily reliant on the tissue-stent interaction. The present study quantified important tissue-stent contact variables of self-expanding transcatheter aortic v
Publikováno v:
Journal of Biomechanics. 45:1965-1971
The objective of this study was to develop a patient-specific computational model to quantify the biomechanical interaction between the transcatheter aortic valve (TAV) stent and the stenotic aortic valve during TAV intervention. Finite element model
Publikováno v:
Cardiovascular Engineering and Technology. 2:186-195
Successful transcatheter aortic valve (TAV) deployment and function are heavily reliant on the implant-host tissue interaction. Many adverse events observed clinically in TAV procedures such as impairment of coronary artery flow, paravalvular leak, a
Publikováno v:
Artificial organs. 40(6)
Impairment of coronary artery flow, in either acute or chronic conditions, is a severe complication of transcatheter aortic valve (TAV) implantation, which can arise due to improper TAV positioning. However, little work has been done to quantify the
Publikováno v:
Journal of medical devices. 7(4)
Transcatheter aortic valve (TAV) replacement holds promise for a large number of patients who otherwise have limited or no treatment options. However, it also poses various challenges, due to its unique disease treatment mechanism. Successful TAV dep
Publikováno v:
2012 38th Annual Northeast Bioengineering Conference (NEBEC).
The purpose of the study is to develop an ex vivo testing methodology to quantify coronary artery flow using a pulsatile left heart simulator. A dissected porcine aorta was mounted on a Vivitro left heart simulator and its coronary artery flow was me
Publikováno v:
2012 38th Annual Northeast Bioengineering Conference (NEBEC).
An experimental and analytical approach were performed to study the biomechanics of a self-expanding, nitinol transcatheter aortic valve (TAV) stent device deployed in porcine heart tissue. The radial force, pullout force, and coefficient of friction
Publikováno v:
ASME 2011 Summer Bioengineering Conference, Parts A and B.
Recently, minimally-invasive transcatheter aortic valve (TAV) replacement has emerged as a viable alternative to traditional open-chest heart valve replacement for high risk patients who otherwise have limited or no treatment options. Although signif